For example, discounting may be significant in the case of autologous chondrocyte implantation (ACI) to treat isolated full-thickness articular cartilage defects of the knee (upfront costs and delayed health benefits) or negligible in intra-articular steroid injections (where costs and benefits occur upfront simultaneously).
← all excerpts
Understanding cost-utility analysis studies in the trauma and orthopaedic surgery literature.
1
—
—